Astrana Health (ASTH) The 44th Annual William Blair Growth Stock Conference summary
Event summary combining transcript, slides, and related documents.
The 44th Annual William Blair Growth Stock Conference summary
1 Feb, 2026Key business highlights
Achieved 26% revenue CAGR over four years, tripling revenue from $500M to $1.75B.
Serves 1M Americans across Medicare, Medicaid, and commercial lines, with a 60/25/15 revenue split.
Operates a network of 10,000 affiliated providers and 60 owned clinics in three states.
Maintains over 98% provider retention, with average tenure exceeding 11 years.
96% of members are in financial risk arrangements, enabling value capture from cost savings.
Technology and care model
Proprietary care enablement platform coordinates care, reduces waste, and improves outcomes.
Machine learning identifies high-risk patients for targeted interventions, such as home visits.
Point-of-care analytics integrated into EHRs guide preventive and evidence-based care.
300 corporate clinicians manage population health, leveraging AI for risk detection.
Technology enables efficient operations, delegated payer tasks, and regulatory compliance.
Financial and clinical outcomes
Hospital admissions per 1,000 seniors are 48% below CMS benchmarks; ER visits are 43% lower.
Achieves 350 basis point reduction in Medical Cost Ratio, reaching profitability in new markets within two years.
Maintains 10% adjusted EBITDA margin, outperforming peers in profitability.
Full risk contracts now comprise 60% of capitated revenue, targeting two-thirds by year-end.
Recent acquisition of Community Family Care at 6x LTM EBITDA, leveraging technology for accretive M&A.
Latest events from Astrana Health
- Record growth, resilient margins, and AI-driven efficiency amid industry headwinds.ASTH
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Record revenue and EBITDA growth achieved, with robust 2026 outlook and Prospect integration.ASTH
Q4 20253 Mar 2026 - Q2 revenue up 40% and net income up 46% year-over-year, with 2024 guidance raised.ASTH
Q2 20242 Feb 2026 - Q3 revenue up 37% to $478.7M; guidance raised after major acquisitions.ASTH
Q3 202415 Jan 2026 - $745M deal expands reach to 1.7M members, targeting $1.2B revenue in 2024.ASTH
M&A Announcement15 Jan 2026 - Delegated risk model, tech-driven care, and payer partnerships drive national growth and profitability.ASTH
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Accelerating value-based care growth with scalable tech, risk-bearing models, and strong financials.ASTH
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - FY2025 targets $2.5–$2.7B revenue and $170–$190M EBITDA, with Prospect Health driving growth.ASTH
TD Cowen 45th Annual Healthcare Conference2 Dec 2025 - 2025 proxy covers director elections, auditor ratification, pay, equity plan, and strong governance.ASTH
Proxy Filing2 Dec 2025